PHIO FY 2019 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21,000-84.8% YoY

Gross Profit

$21,000100.0% margin

Operating Income

-$9M-42795.2% margin

Net Income

-$9M-42419.0% margin

EPS (Diluted)

$-2074.18

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$300,000

Balance Sheet

Total Assets

$8M

Total Liabilities

$2M

Stockholders' Equity

$6M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21,000	$138,000	-84.8%
Gross Profit	$21,000	-$4M	+100.5%
Operating Income	-$9M	-$7M	-22.0%
Net Income	-$9M	-$7M	-21.0%